Abstract
Because data describing drug excretion into human milk are generally lacking, pharmacokinetics (PK)-based prediction of infant drug exposure levels is clinically meaningful. Such PK-based prediction indicates that drugs with relatively low clearance (<1 ml/kg/min) in adults should be used with caution during breastfeeding, because their use may lead to relatively high levels of infant exposure due to even lower clearance in the infant. Complementing the PK-based prediction, a comprehensive, up-to-date information resource such as LactMed has proven useful. Given the established health benefits of human milk, ranging from anti-infective activity to enhancement of cognitive function in the infant, careful and individualized risk assessment is justified. However, when translating available knowledge into practice, it is important to recognize that risk–benefit balance in drug safety during breastfeeding varies among in different socioeconomic settings, as exemplified in anti-HIV treatment for lactating women.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Ito S, Koren G. A novel index for expressing exposure of the infant to drug in breast milk. Br J Clin Pharmacol. 1994;38:99–102.
Ito S. Drug therapy for breast-feeding women. N Engl J Med. 2000;343:118–26.
Koren G, Cairns J, Chitayat D, Gaedigk A, Leeder SJ. Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother. Lancet. 2006;368:704.
Akus M, Bartick M. Lactation safety recommendations and reliability compared in 10 medication resources. Ann Pharmacother. 2007;41:1352–60.
Gartner LM, Morton J, Lawrence RA, Naylor AJ, O’Hare D, Schanler RJ, et al. Breastfeeding and the use of human milk. Pediatrics. 2005;115:496–506.
Duijts L, Jaddoe VWV, Hofman A, Moll HA. Prolonged and exclusive breastfeeding reduces the risk of infectious diseases in infancy. Pediatrics. 2010;126:e18–25.
Kramer MS, Chalmers B, Hodnett ED, Sevkovskaya Z, Dzikovich I, Shapiro S, et al. Promotion of Breastfeeding Intervention Trial (PROBIT): a randomized trial in the Republic of Belarus. JAMA. 2001;285:413–20.
Kramer MS, Aboud F, Mironova E, Vanilovich I, Platt RW, Matush L, et al. Breastfeeding and child cognitive development: new evidence from a large randomized trial. Arch Gen Psychiatry. 2008;65:578–84.
Black RE, Allen LH, Bhutta ZA, Caulfield LE, De Onis M, Ezzati M, et al. Maternal and child undernutrition: global and regional exposures and health consequences. Lancet. 2008;371:243–60.
Coovadia HM, Rollins NC, Bland RM, Little K, Coutsoudis A, Bennish ML, et al. Mother-to-child transmission of HIV-1 infection during exclusive breastfeeding in the first 6 months of life: an intervention cohort study. Lancet. 2007;369:1107–16.
World Health Organization. Guidelines on HIV and infant feeding. Principles and recommendations for infant feeding in the context of HIV and a summary of evidence; 2010 http://whqlibdoc.who.int/publications/2010/9789241599535_eng.pdf?ua=1. Accessed 10 Oct 2014.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Ito, S. (2015). Drugs and Breastfeeding: The Knowledge Gap. In: MacLeod, S., Hill, S., Koren, G., Rane, A. (eds) Optimizing Treatment for Children in the Developing World. Adis, Cham. https://doi.org/10.1007/978-3-319-15750-4_8
Download citation
DOI: https://doi.org/10.1007/978-3-319-15750-4_8
Publisher Name: Adis, Cham
Print ISBN: 978-3-319-15749-8
Online ISBN: 978-3-319-15750-4
eBook Packages: MedicineMedicine (R0)